drug
aprotinin + fibrinogen (human) + thrombin (human)
Marketedupdated 3mo agoby Baxter Healthcare Corp
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying aprotinin + fibrinogen (human) + thrombin (human)
- phase2Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU)
- phase2Study to Evaluate the Safety, Tolerability, and Efficacy of PEP-TISSEEL in Subjects With Chronic Radiation Ulcer
- phase1PEP on a Skin Graft Donor Site Wound
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that